Dr. Noriyuki Kasahara, MD, PhD

Claim this profile
Studies Glioblastoma
Studies Cerebral Gliomas
1 reported clinical trial
4 drugs studied

Area of expertise

1Glioblastoma
Noriyuki Kasahara, MD, PhD has run 1 trial for Glioblastoma. Some of their research focus areas include:
IDH positive
DGM7 positive
DGM7 negative
2Cerebral Gliomas
Noriyuki Kasahara, MD, PhD has run 1 trial for Cerebral Gliomas. Some of their research focus areas include:
IDH positive
DGM7 positive
DGM7 negative

Clinical Trials Noriyuki Kasahara, MD, PhD is currently running

Image of trial facility.

DB107-RRV + DB107-FC

for Brain Tumors

This is a multicenter, open-label study of DB107-RRV (formerly Toca 511) and DB107-FC (formerly Toca FC) when administered following surgical resection in newly diagnosed High Grade Glioma (HGG) patients. The study is designed to evaluate whether treatment with DB107-RRV in combination with DB107-FC when added to standard of care provides clinical benefit to newly diagnosed HGG when compared to historical performance previously determined in well controlled clinical trials published in the peer reviewed literature. This study is going to be conducted in newly diagnosed HGG patients receiving with maximum surgical resection treatment followed by radiation and temozolomide treatment using the established Stupp Protocol for O6-methylguanine-DNA methyl-transferase (MGMT) methylated patients or radiation therapy for MGMT unmethylated patients.
Recruiting1 award Phase 1 & 25 criteria

More about Noriyuki Kasahara, MD, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Noriyuki Kasahara, MD, PhD has experience with
  • DB107-FC
  • DB107-RRV
  • Radiation Therapy
  • Temozolomide
Breakdown of trials Noriyuki Kasahara, MD, PhD has run
Glioblastoma
Cerebral Gliomas
Brain Cancer
Brain Tumor

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Noriyuki Kasahara, MD, PhD specialize in?
Noriyuki Kasahara, MD, PhD focuses on Glioblastoma and Cerebral Gliomas. In particular, much of their work with Glioblastoma has involved IDH positive patients, or patients who are DGM7 positive.
Is Noriyuki Kasahara, MD, PhD currently recruiting for clinical trials?
Yes, Noriyuki Kasahara, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Noriyuki Kasahara, MD, PhD has studied deeply?
Yes, Noriyuki Kasahara, MD, PhD has studied treatments such as DB107-FC, DB107-RRV, Radiation Therapy.
What is the best way to schedule an appointment with Noriyuki Kasahara, MD, PhD?
Apply for one of the trials that Noriyuki Kasahara, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top